BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38349762)

  • 1. Corticosteroids impair epithelial regeneration in immune-mediated intestinal damage.
    Arnhold V; Chang WY; Jansen SA; Thangavelu G; Calafiore M; Vinci P; Fu YY; Ito T; Takashima S; Egorova A; Kuttiyara J; Perlstein A; van Hoesel M; Liu C; Blazar BR; Lindemans CA; Hanash AM
    J Clin Invest; 2024 Feb; 134(7):. PubMed ID: 38349762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration.
    Lindemans CA; Calafiore M; Mertelsmann AM; O'Connor MH; Dudakov JA; Jenq RR; Velardi E; Young LF; Smith OM; Lawrence G; Ivanov JA; Fu YY; Takashima S; Hua G; Martin ML; O'Rourke KP; Lo YH; Mokry M; Romera-Hernandez M; Cupedo T; Dow L; Nieuwenhuis EE; Shroyer NF; Liu C; Kolesnick R; van den Brink MRM; Hanash AM
    Nature; 2015 Dec; 528(7583):560-564. PubMed ID: 26649819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease.
    Melson J; Jakate S; Fung H; Arai S; Keshavarzian A
    Am J Hematol; 2007 Oct; 82(10):881-6. PubMed ID: 17570511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Me6TREN targets β-catenin signaling to stimulate intestinal stem cell regeneration after radiation.
    Wang S; Han Y; Zhang J; Yang S; Fan Z; Song F; He L; Yue W; Li Y; Pei X
    Theranostics; 2020; 10(22):10171-10185. PubMed ID: 32929341
    [No Abstract]   [Full Text] [Related]  

  • 5. Regeneration After Radiation- and Immune-Mediated Tissue Injury Is Not Enhanced by Type III Interferon Signaling.
    Fischer JC; Lin CC; Heidegger S; Wintges A; Schlapschy M; Beudert M; Combs SE; Bassermann F; Skerra A; Haas T; Poeck H
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(4):970-976. PubMed ID: 30503785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RIG-I/MAVS and STING signaling promote gut integrity during irradiation- and immune-mediated tissue injury.
    Fischer JC; Bscheider M; Eisenkolb G; Lin CC; Wintges A; Otten V; Lindemans CA; Heidegger S; Rudelius M; Monette S; Porosnicu Rodriguez KA; Calafiore M; Liebermann S; Liu C; Lienenklaus S; Weiss S; Kalinke U; Ruland J; Peschel C; Shono Y; Docampo M; Velardi E; Jenq RR; Hanash AM; Dudakov JA; Haas T; van den Brink MRM; Poeck H
    Sci Transl Med; 2017 Apr; 9(386):. PubMed ID: 28424327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-λ therapy prevents severe gastrointestinal graft-versus-host disease.
    Henden AS; Koyama M; Robb RJ; Forero A; Kuns RD; Chang K; Ensbey KS; Varelias A; Kazakoff SH; Waddell N; Clouston AD; Giri R; Begun J; Blazar BR; Degli-Esposti MA; Kotenko SV; Lane SW; Bowerman KL; Savan R; Hugenholtz P; Gartlan KH; Hill GR
    Blood; 2021 Aug; 138(8):722-737. PubMed ID: 34436524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
    Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
    Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IL-33/ST2 axis augments effector T-cell responses during acute GVHD.
    Reichenbach DK; Schwarze V; Matta BM; Tkachev V; Lieberknecht E; Liu Q; Koehn BH; Pfeifer D; Taylor PA; Prinz G; Dierbach H; Stickel N; Beck Y; Warncke M; Junt T; Schmitt-Graeff A; Nakae S; Follo M; Wertheimer T; Schwab L; Devlin J; Watkins SC; Duyster J; Ferrara JL; Turnquist HR; Zeiser R; Blazar BR
    Blood; 2015 May; 125(20):3183-92. PubMed ID: 25814531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin attenuates acute gastrointestinal graft-versus-host disease by preventing apoptosis of intestinal epithelial cells.
    Kawakami K; Minami N; Matsuura M; Iida T; Toyonaga T; Nagaishi K; Arimura Y; Fujimiya M; Uede T; Nakase H
    Biochem Biophys Res Commun; 2017 Apr; 485(2):468-475. PubMed ID: 28192120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCN057 induces intestinal stem cell repair and mitigates radiation-induced intestinal injury.
    Bhanja P; Norris A; Gupta-Saraf P; Hoover A; Saha S
    Stem Cell Res Ther; 2018 Feb; 9(1):26. PubMed ID: 29394953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel RIPK1 inhibitor reduces GVHD in mice via a nonimmunosuppressive mechanism that restores intestinal homeostasis.
    Yu X; Ma H; Li B; Ji Y; Du Y; Liu S; Li Z; Hao Y; Tian S; Zhao C; Du Q; Jin Z; Zhu X; Tian Y; Chen X; Sun X; Yang C; Zhu F; Ju J; Zheng Y; Zhang W; Wang J; Yang T; Wang X; Li J; Xu X; Du S; Lu H; Ma F; Zhang H; Zhang Y; Zhang X; Hu S; He S
    Blood; 2023 Mar; 141(9):1070-1086. PubMed ID: 36356302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival signal REG3α prevents crypt apoptosis to control acute gastrointestinal graft-versus-host disease.
    Zhao D; Kim YH; Jeong S; Greenson JK; Chaudhry MS; Hoepting M; Anderson ER; van den Brink MR; Peled JU; Gomes AL; Slingerland AE; Donovan MJ; Harris AC; Levine JE; Ozbek U; Hooper LV; Stappenbeck TS; Ver Heul A; Liu TC; Reddy P; Ferrara JL
    J Clin Invest; 2018 Nov; 128(11):4970-4979. PubMed ID: 30106382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Aged Dysfunctional Intestinal Stem Cells.
    Nalapareddy K; Geiger H
    Methods Mol Biol; 2020; 2171():41-52. PubMed ID: 32705634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T Cell Recruitment to the Intestinal Stem Cell Compartment Drives Immune-Mediated Intestinal Damage after Allogeneic Transplantation.
    Fu YY; Egorova A; Sobieski C; Kuttiyara J; Calafiore M; Takashima S; Clevers H; Hanash AM
    Immunity; 2019 Jul; 51(1):90-103.e3. PubMed ID: 31278057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humans.
    Norona J; Apostolova P; Schmidt D; Ihlemann R; Reischmann N; Taylor G; Köhler N; de Heer J; Heeg S; Andrieux G; Siranosian BA; Schmitt-Graeff A; Pfeifer D; Catalano A; Frew IJ; Proietti M; Grimbacher B; Bulashevska A; Bhatt AS; Brummer T; Clauditz T; Zabelina T; Kroeger N; Blazar BR; Boerries M; Ayuk F; Zeiser R
    Blood; 2020 Sep; 136(12):1442-1455. PubMed ID: 32542357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges and opportunities targeting mechanisms of epithelial injury and recovery in acute intestinal graft-versus-host disease.
    Jansen SA; Nieuwenhuis EES; Hanash AM; Lindemans CA
    Mucosal Immunol; 2022 Apr; 15(4):605-619. PubMed ID: 35654837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells.
    Takashima S; Kadowaki M; Aoyama K; Koyama M; Oshima T; Tomizuka K; Akashi K; Teshima T
    J Exp Med; 2011 Feb; 208(2):285-94. PubMed ID: 21282378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease.
    Mohamed FA; Thangavelu G; Rhee SY; Sage PT; O'Connor RS; Rathmell JC; Blazar BR
    Front Immunol; 2021; 12():757836. PubMed ID: 34712243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.